Trial Profile

A Phase 2 randomized, placebo-controlled, double-blind human challenge study conducted to verify the efficacy and safety of S-337395

Status: Not stated

Phase of Trial: Phase II

Latest Information Update: 06 Feb 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs S-337395 (Primary)
Indications Respiratory syncytial virus infections
Focus Pharmacokinetics

Most Recent Events

06 Feb 2025 New trial record
30 Jan 2025 Results published in the Shionogi media release
30 Jan 2025 According to Shionogi media release, Primary endpoint ( area under the curve (AUC) of the viral load over time) has been met.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com